Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn Disease

IMPORTANCE: Biological therapies have revolutionized inflammatory bowel disease management, but many patients do not respond to biological monotherapy. Identification of likely responders could reduce costs and delays in remission. OBJECTIVE: To identify patients with Crohn disease likely to be dura...

Descripción completa

Detalles Bibliográficos
Autores principales: Waljee, Akbar K., Wallace, Beth I., Cohen-Mekelburg, Shirley, Liu, Yumu, Liu, Boang, Sauder, Kay, Stidham, Ryan W., Zhu, Ji, Higgins, Peter D. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512283/
https://www.ncbi.nlm.nih.gov/pubmed/31074823
http://dx.doi.org/10.1001/jamanetworkopen.2019.3721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512283/
https://www.ncbi.nlm.nih.gov/pubmed/31074823
http://dx.doi.org/10.1001/jamanetworkopen.2019.3721

Ejemplares similares